• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Position statement of the Brazilian Psychiatric Association on the use of cannabis in psychiatric treatment.

作者信息

da Silva Antônio Geraldo, Baldaçara Leonardo

机构信息

Associação Brasileira de Psiquiatria, Rio de Janeiro, RJ, Brazil. Faculdade de Medicina, Universidade do Porto, Porto, Portugal. Programa de Pós-Graduação em Medicina Molecular, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.

Associação Brasileira de Psiquiatria, Rio de Janeiro, RJ, Brazil. Curso de Medicina, Universidade Federal do Tocantins (UFT), Palmas, Tocantins, Brazil.

出版信息

Braz J Psychiatry. 2022 Aug 23;44(6):572-573. doi: 10.47626/1516-4446-2022-0043.

DOI:10.47626/1516-4446-2022-0043
PMID:35870135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9851767/
Abstract
摘要

相似文献

1
Position statement of the Brazilian Psychiatric Association on the use of cannabis in psychiatric treatment.巴西精神病学协会关于大麻在精神科治疗中使用的立场声明。
Braz J Psychiatry. 2022 Aug 23;44(6):572-573. doi: 10.47626/1516-4446-2022-0043.
2
Cannabis in psychiatric disorders: the cart before the horse?大麻与精神疾病：本末倒置？
Lancet Psychiatry. 2019 Dec;6(12):968-969. doi: 10.1016/S2215-0366(19)30375-X. Epub 2019 Oct 28.
3
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.大麻会引发、加剧还是改善精神疾病？对一场过度简化的辩论的探讨
Neuropsychopharmacology. 2016 Jan;41(2):393-401. doi: 10.1038/npp.2015.251. Epub 2015 Aug 19.
4
[Cannabis abuse in patients with psychiatric disorders: an update to old evidence].[精神疾病患者中的大麻滥用：旧证据的更新]
Braz J Psychiatry. 2010 May;32 Suppl 1:S41-5.
5
Cannabis use is associated with lower retention in methadone maintenance treatment, but not among schizophrenic- and other chronically psychotic patients.使用大麻与美沙酮维持治疗的留存率较低有关，但在精神分裂症患者和其他慢性精神病患者中并非如此。
J Addict Dis. 2022 Apr-Jun;40(2):183-191. doi: 10.1080/10550887.2021.1962209. Epub 2021 Aug 11.
6
Resting-state network connectivity in cannabis-induced psychosis: Is it different from first episode schizophrenia with heavy cannabis use?大麻所致精神病的静息态网络连接性：它与大量使用大麻的首发精神分裂症有何不同？
Asian J Psychiatr. 2022 Sep;75:103201. doi: 10.1016/j.ajp.2022.103201. Epub 2022 Jul 2.
7
Cannabis use and psychosis susceptibility: A call to action.大麻使用与精神病易感性：行动呼吁。
Eur Neuropsychopharmacol. 2022 Jan;54:70-71. doi: 10.1016/j.euroneuro.2021.09.004. Epub 2021 Sep 24.
8
[The Cannabis Abuse Screening Test (CAST) for psychiatric disorders diagnosis in young cannabis users].
Adicciones. 2013;25(1):87-8.
9
[Related, induced and associated psychiatric disorders to cannabis].[与大麻相关、由大麻诱发及伴发的精神障碍]
Rev Prat. 2005 Jan 15;55(1):30-4.
10
[Cannabis use disorders and psychiatric comorbidities].[大麻使用障碍与精神共病]
Rev Prat. 2018 Jun;68(6):670-674.

本文引用的文献

1
Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife.长期吸食大麻与中年认知储备和海马体体积的关系。
Am J Psychiatry. 2022 May;179(5):362-374. doi: 10.1176/appi.ajp.2021.21060664. Epub 2022 Mar 8.
2
A scoping review of the use of cannabidiol in psychiatric disorders.精神障碍中使用大麻二酚的范围综述。
Psychiatry Res. 2022 Feb;308:114347. doi: 10.1016/j.psychres.2021.114347. Epub 2021 Dec 20.
3
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study.产前大麻暴露与儿童期结局的关联：ABCD 研究的结果。
JAMA Psychiatry. 2021 Jan 1;78(1):64-76. doi: 10.1001/jamapsychiatry.2020.2902.
4
The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.大麻二酚油在精神分裂症治疗中的作用。系统评价和荟萃分析。
Psychiatry Res. 2020 Sep;291:113246. doi: 10.1016/j.psychres.2020.113246. Epub 2020 Jun 22.
5
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.用于治疗精神障碍及精神障碍症状的大麻素：一项系统评价与荟萃分析
Lancet Psychiatry. 2019 Dec;6(12):995-1010. doi: 10.1016/S2215-0366(19)30401-8. Epub 2019 Oct 28.
6
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis.青少年时期大麻使用与成年早期抑郁、焦虑和自杀风险的关联：系统评价和荟萃分析。
JAMA Psychiatry. 2019 Apr 1;76(4):426-434. doi: 10.1001/jamapsychiatry.2018.4500.
7
Is cannabidiol an effective treatment for schizophrenia?大麻二酚对精神分裂症是一种有效的治疗方法吗？
Medwave. 2017 Aug 9;17(7):e7010. doi: 10.5867/medwave.2017.07.7010.
8
Cannabis and schizophrenia.大麻与精神分裂症。
Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3.